Home NDC 70515-105 BETAPACE
Product NDC 70515-105
11-digit product format 705150105
Labeler code 70515
Product ID 70515-105_1b3fb38e-5546-4a55-866f-d2e2ffadaed8
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name sotalol hydrochloride
Dosage form TABLET
Route ORAL
Labeler Covis Pharma US, Inc
Application NDA019865
Marketing category NDA
Marketing start 2016-09-01
Marketing end 0000-00-00
Substance SOTALOL HYDROCHLORIDE
Active strength 80 mg/1
Pharmacologic classes Adrenergic beta-Antagonists [MoA], Antiarrhythmic [EPC], Cardiac Rhythm Alteration [PE]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 18 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 70515-105-10 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 70515-105-10 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 70515-105-10 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 70515-105-10 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 70515-105-10 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 70515-105-10 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 70515-105-10 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 70515-105-10 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 70515-105-10 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N019865-001 BETAPACE SOTALOL HYDROCHLORIDE 80MG TABLET / ORAL AB RLD 1992-10-30 N019865-002 BETAPACE SOTALOL HYDROCHLORIDE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 N019865-003 BETAPACE SOTALOL HYDROCHLORIDE 240MG TABLET / ORAL AB RLD 1992-10-30 N019865-004 BETAPACE SOTALOL HYDROCHLORIDE 320MG TABLET / ORAL 1992-10-30 N019865-005 BETAPACE SOTALOL HYDROCHLORIDE 120MG TABLET / ORAL AB RLD 1994-04-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 205 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-001 BETAPACE 80MG TABLET / ORAL AB RLD 1992-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-002 BETAPACE 160MG TABLET / ORAL AB RLD, RS 1992-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-003 BETAPACE 240MG TABLET / ORAL AB RLD 1992-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-004 BETAPACE 320MG TABLET / ORAL 1992-10-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N019865-005 BETAPACE 120MG TABLET / ORAL AB RLD 1994-04-20 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70515-105-10 BETAPACE 100 in 1 BOTTLE TABLET 100 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70515-105 BETAPACE (SOTALOL HYDROCHLORIDE) TABLET BETAPACE AF (SOTALOL HYDROCHLORIDE) TABLET [COVIS PHARMA US, INC] 6 Legacy NDC, 1 package rows 20230629_afce2787-8899-4098-87c8-f1e8dd19e6dd.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join BETAPACE SOTALOL HYDROCHLORIDE Legacy Pharma USA, Inc. a6a7702f-36c9-45db-b640-453dc324baee 2024-12-16 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 019865 application number: NDA019865
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70515-105-10 70515010510 100 TABLET in 1 BOTTLE (70515-105-10) 100 tablet 2016-09-01 0000-00-00 No No Current